BMY
BMY
NYSE · Pharmaceuticals

Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$56.16
-0.09 (-0.16%)
As of May 8, 9:31 PM ET ·
Analyst Consensus
Hold
36
Analysts
Very High
Coverage
Buy 15 42%
Hold 19 53%
Sell 2 6%
Price Target
Analyst Price Target +210.7% upside
Low Target $130.78
Average Target $174.50
High Target $195.10
Current Price $56.16
Current
$56.16
Target
$174.50
$130.78 $174.50 avg $195.10
Scenario Analysis
Bear Case
$130.78
132.9%
Low target
Base Case
$174.50
+210.7%
Avg target
Bull Case
$195.10
+247.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$62.89
-10.7% from high
52-Week Low
$42.52
+32.1% from low
50-Day SMA
$55.66
+0.9% vs SMA
200-Day SMA
$49.00
+14.6% vs SMA
RSI (14)
74.1
Overbought
Target vs 52W High
$174.50
+177.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
 Hold 45 51% — +0.0%
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
 Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
 Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
 Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
 Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -28.6%